Baird Medical Investment Holdings Limited (BDMD) Stock

Baird Medical Investment Holdings Limited (BDMD) is a Healthcare stock trading at $1.17 (as of 2026-06-18), with a market capitalization of $50.68M and a trailing P/E of -1.3. Figures are sourced from first-party U.S. SEC EDGAR filings and market data.

Baird Medical Investment Holdings Limited, together with its subsidiaries develops and sells microwave ablation medical devices for minimally invasive tumor treatment in China. The company's medical devices are used for treatment of benign and malignant tumors, including thyroid nodules, liver cancer, lung cancer, and breast lumps. Baird Medical Investment Holdings Limited was founded in 2012 and is headquartered in Guangzhou, China.

Valuation — source: SEC EDGAR (first-party)
Price	$1.17
Market Cap	$50.68M
P/E Ratio	-1.3
EV / EBITDA	-1.9
Price / Book	1.23
Price / Sales	1.71
DCF Value (model)	$-1.03
DCF Upside vs Price	-188.0%

Profitability & Growth — source: SEC EDGAR
Revenue (TTM)	$22.54M
Net Margin	-121.0%
Return on Equity	-87.4%
Debt / Equity	0.28
Current Ratio	1.70
Revenue Growth (YoY)	-39.2%
EPS Growth (YoY)	-300.0%
FCF Growth (YoY)	-84.9%

Financial Health — source: SEC EDGAR
Altman Z-Score	0.05 (distress)
Piotroski F-Score	1/9 (weak)

Valuation vs Sector & Industry
Stock P/E	-1.3
Sector P/E (Healthcare)	21.0
Industry P/E (Medical Equipment)	31.7
vs Sector	-106.1%
vs Industry	-104.0%

Smart-Money Activity — SEC Form 4 / 13F / Congressional disclosures
Top Institutional Holder	HIGHBRIDGE CAPITAL MANAGEMENT LLC ($230000.00)
Institutional Holders Tracked	10

Company
Sector	Healthcare
Industry	Medical Equipment
CEO	Haimei Wu
Employees	148
Country	CN
IPO Date	2021-12-16

Related Companies (Business model: Medical Devices / Life Science Tools; 8 closest by market cap; US-domiciled)

Data as of 2026-06-18.

Figures sourced from U.S. Securities and Exchange Commission (SEC EDGAR) filings and market data. Not personalized investment advice.